It’s a historic first but will it be enough? It promises that by the end of next year, no more animals will have their sensitive eyes damaged by chemicals in eye irritation tests, and no animals will ...

Neonatal EOS, a severe bloodstream infection that strikes within the first three days of life, is a major cause of infant ...

ABIONYX Pharma, (FR0012616852 - ABNX - eligible PEA PME), a next-generation biopharma company pioneering a new therapeutic era in sepsis and critical care through its proprietary apoA-I-based ...

Inmates with a history of drug use are at particular risk of dying from untreated sepsis in US prisons and jails, USA TODAY ...

While doctors at the Cleveland Clinic have focused on reducing sepsis mortality through early detection and intervention for years, they see AI as another tool that could help combat the condition.

For years, the approach to sepsis in acute care settings has been the same: early warning alerts and standardized care protocols. Unfortunately, it hasn’t moved the needle. Sepsis still affects 2.5 ...

When hearing about new uses of AI, I think some people imagine the innovation is just asking ChatGPT a question. If that was truly happening, that should inspire a lot ...

OCEAN Dx is completing the industrialization of its sepsis test and plans clinical trials in 2026, targeting CE marking. OCEAN Dx will launch its rapid sepsis diagnostic test in Europe by 2029.

A rapid diagnostic test from Ocean Dx SAS delivered gold standard performance in a clinical evaluation that points to a potential shift in how sepsis is identified and treated. The assay, which ...

A new discovery from the lab of YouYang Zhao, Ph.D., from Stanley Manne Children's Research Institute at Ann & Robert H.